CS logo
small CS logo
Tagestherapiezentrum am ITM Universitätsmedizin Mannheim

Mannheim, Germany
Krebstherapiezentrum in Mannheim, Baden-Württemberg

About Tagestherapiezentrum am ITM Universitätsmedizin Mannheim


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
3
AIO-Studien-gGmbH
1
WiSP Wissenschaftlicher Service Pharma GmbH
1
Total Rows: 3

Clinical Trials at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim


During the past decade, Tagestherapiezentrum am ITM Universitätsmedizin Mannheim conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years111111000000Started TrialsCompleted Trails20182019202000.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III)
2010-12-01
2016-07-01
Unknown status
59
Explorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or Stomach
2011-12-01
2016-09-12
Completed
53
RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients
2019-01-24
2024-06-01
Active, not recruiting
430
Aflibercept and 5-FU vs. FOLFOX as 1st Line Treatment for Elderly or Frail Elderly Patients With Met. Colorectal Cancer
2018-09-28
2023-12-15
Active, not recruiting
124
Ramucirumab Plus TAS-102 in Patients With Advanced or Metastatic Gastric Adenocarcinoma or the Gastroesophageal Junction
2020-10-15
2023-01-20
Completed
20

Rows per page:

1–5 of 5

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" #1 collaborator was "Trium Analysis Online GmbH" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator and "STABIL - Statistische und Biometrische Lösungen" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsInstitut für KlinischeKrebsforschung IKFGmbH at KrankenhausNordwest: 3Institut für KlinischeKrebsforschung IKFGmbH at KrankenhausNordwest: 3AIO-Studien-gGmbH: 1AIO-Studien-gGmbH: 1WiSP WissenschaftlicherService Pharma GmbH:1WiSP WissenschaftlicherService Pharma GmbH:1

Created with Highcharts 11.1.0Top CollaboratorsTrium Analysis Online GmbH: 2Trium Analysis Online GmbH: 2Eli Lilly and Company: 1Eli Lilly and Company: 1Gesellschaft furMedizinische Innovation- Hamatologie undOnkologie mbH: 1Gesellschaft furMedizinische Innovation- Hamatologie undOnkologie mbH: 1Roche Pharma AG: 1Roche Pharma AG: 1STABIL - Statistischeund BiometrischeLösungen: 1STABIL - Statistischeund BiometrischeLösungen: 1Sanofi: 1Sanofi: 1

Clinical Trials Conditions at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim


According to Clinical.Site data, the most researched conditions in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" are "Colorectal Cancer" (2 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials), "Adenocarcinoma of the Stomach" (1 trials), "Gastric Adenocarcinoma" (1 trials) and "Metastatic Adenocarcinoma of the Gastroesophageal Junction" (1 trials). Many other conditions were trialed in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" in a lesser frequency.

Clinical Trials Intervention Types at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim


Most popular intervention types in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" are "Drug" (5 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ramucirumab" (2 trials), "TAS 102" (2 trials), "5-FU, leucovorin, docetaxel, oxaliplatin (FLOT), trastuzumab" (1 trials), "Aflibercept + mLV5FU2" (1 trials) and "Panitumumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim


The vast majority of trials in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim" are 5 trials for "All" genders.

Clinical Trials Status at Tagestherapiezentrum am ITM Universitätsmedizin Mannheim


Currently, there are NaN active trials in "Tagestherapiezentrum am ITM Universitätsmedizin Mannheim". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tagestherapiezentrum am ITM Universitätsmedizin Mannheim, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Tagestherapiezentrum am ITM Universitätsmedizin Mannheim, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 3Phase 2: 3Not Applicable: 1Not Applicable: 1Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 2Active, not recruiting: 2Completed: 2Completed: 2Unknown status: 1Unknown status: 1